Product Details

Vercal-CG is a sterile, non-pyrogenic injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Calcium Gluconate equivalent to 10% w/v elemental calcium for use through the intravenous (I.V.) or intramuscular (I.M.) route. As a result, it offers a reliable calcium replacement solution for the correction of hypocalcaemia and related conditions.

The injection contains:

• Calcium Gluconate IP (equivalent to Calcium 10% w/v) – An essential electrolyte that restores serum calcium levels and supports normal neuromuscular, cardiac, and coagulation function. Consequently, it stabilizes cell membrane excitability and helps correct symptomatic or severe hypocalcaemia.

Physicians use Vercal-CG for the treatment of acute hypocalcaemia arising from conditions such as hypoparathyroidism, vitamin D deficiency, and renal disease, as well as for the management of hyperkalaemia-related cardiac toxicity, where calcium stabilizes cardiac membrane potential. In addition, its dual-route (I.V./I.M.) formulation allows flexible administration based on clinical urgency. Because of this profile, Vercal-CG suits hospitals, ICUs, and emergency departments where prompt calcium correction is essential.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the sterile, non-pyrogenic formulation supports safe IV/IM administration
• Furthermore, each single-dose vial delivers precise, validated dosage accuracy at 10% w/v
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, ICUs, and emergency care units